Electrolytes are scientifically termed salts. By controlling nerve and muscle function, hydrating the body, balancing blood acidity and pressure, and regulating nerve and muscle function, they aid in healing wounded tissue. Muscles and neurons are sometimes referred to as the body's "electric tissues." Electrolytes must flow through the fluid within, outside, or between cells for electrolytes to act.
The global multiple electrolytes injection market is expected to grow at a CAGR of 7.90% during 2021–2029.
The electrolytes found in the human body include:
Multiple electrolytes injection is a sterile solution injected into a vein in your body. It provides patients with fluids when they cannot drink enough liquids. The multiple electrolytes injection market is segmented based on type, application, and region.
Globally, the geriatric population is on the rise. According to the World Health Organization (WHO), the global population of 60 years and above is predicted to reach 2 billion by 2050, up from 900 million in 2015. China alone is anticipated to have 120 million individuals aged 80 and above by 2050, while the worldwide geriatric population will top 434 million.
Due to low immunity, deteriorating health, and growing age, the elderly population is more susceptible to chronic diseases. Individuals in this age group are more likely to have one or more chronic diseases such as cancer and hypertension. Furthermore, the prevalence of chronic diseases due to lifestyle changes has risen worldwide.
According to the WHO estimates, "Cancer is the second leading cause of mortality worldwide, with 9.6 million deaths due to cancer in 2018." According to the Australian Bureau of Statistics (ABS), 2017–18 National Health Survey, an estimated 1.2 million persons aged 18 and above in Australia suffered from one or more cardiac or vascular disorders, including stroke. As a result, there is always a significant demand for therapeutic and management choices.
The symptoms of electrolyte intoxication vary slightly based on the body's electrolytes level. Since electrolyte drinks contain many electrolytes, too much of one electrolyte may cause another to become depleted. According to the Merck Manual, patients with hypernatremia are likely to be thirsty, and if the disease develops, they may experience confusion, seizures, and muscular twitching. Also, there may be no symptoms in situations of mild hyperkalemia. Muscle weakness can occur in some people, and it can induce irregular heart rhythms and even cause the heart to stop if it is severe enough. These factors are expected to impede the multiple electrolytes injection market growth during the forecast period.
Government initiatives, media influence, and extensive marketing campaigns have boosted awareness of electrolytes solutions by a factor of ten in recent years. According to an article by the British Specialist Nutrition Association, specialist nutrition industry groups such as Specialized Nutrition Europe (SNE) and the Medical Nutrition International Industry (MNI) in February 2021 jointly welcomed the publication of Europe's Beating Cancer Plan.
This covers strategies that might help cancer patients heal faster and have a higher survival rate. The plan recognizes the need for nutritional support, which has been shown to improve cancer patients' ability to cope with disease and treatment. Furthermore, increased disposable income in developing countries such as India and China and rising heart and kidney problems are projected to propel the multiple electrolytes injection market growth.
The coronavirus (COVID-19) pandemic and lockdowns in several locations worldwide impacted enterprises of all types. The private healthcare sector is one of the areas where the COVID-19 pandemic had a big hit.
The healthcare sector has been put under financial strain due to the lockdown regulations in several countries. Furthermore, the pandemic impacted the development, production, supply of medications and other healthcare items, and expansion of numerous healthcare enterprises globally.
COVID-19 patients with COVID-19 face several issues related to kidneys, gastrointestinal tract, and others. In COVID-19 patients, fluid and electrolyte abnormalities are consequences of renal and GI damage. Since fluid and electrolyte disturbances can cause a variety of problems, including death, clinicians should keep a close eye on fluid and electrolyte balance in COVID-19 patients, particularly those in intensive care, where the risk of fluid and electrolyte disturbance is higher, and the mortality rate is higher. Specific attention should be given to the most prevalent fluid and electrolyte problems in SARS-CoV-2 infection.
Hyponatremia, hypernatremia, hypokalemia, hypocalcemia, hypochloremia, and changes in fluid body volume; if these abnormalities are discovered, definite and rapid treatment should be initiated, such as numerous electrolyte injections. As COVID-19 shows fluid and electrolyte abnormalities, body fluid volume and electrolyte concentrations can be used to assess illness status and progression. These factors are anticipated to positively impact the multiple electrolytes injection market during the assessment period.
The multiple electrolytes injection market, by type, is divided into 250ml/Bag, 500ml/Bag, and 1000ml/Bag. In 2021, the 250ml/Bag type segment held the most significant market share. The growing geriatric population, rise in incidences of lifestyle and chronic diseases, and growth in awareness about nutrition benefits in disease management are a few factors driving growth for the segment.
Based on application, the global multiple electrolytes injection market is segmented into hospitals, clinics, and pharmacies. In 2021, the hospital's segment had the highest market share, and it is expected to grow at the fastest rate over the forecast period. The number of cancer treatments conducted in these institutions accounts for the segment's substantial share and robust growth rate.
North America was the largest market for multiple electrolytes injection in 2021, followed by Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Medical nutrition is a lucrative and well-established sector in North America.
The main drivers for the growth of the multiple electrolytes injection market in North America are:
Furthermore, producers pay particular attention to consumer concerns about increased nutritional needs. Increasing risk of chronic illnesses at an older age and malnutrition prevalence in developing countries has compelled market players to develop products to meet individual dietary requirements.
Europe is the second-largest market for multiple electrolytes injection and is expected to grow at the highest CAGR of 8.06% by 2029. This is attributed to the growth in awareness about electrolyte imbalance and related products, increasing health expenditure, increasing chronic diseases and disorders, and a high geriatric population base.
Some of the key players in the global multiple electrolytes injection market are Baxter, B Braun, Otsuka Pharmaceutical, ICU Medical, Fresenius Kabi, Hospira, Pentagon Labs, VetOne, Dechra Pharmaceuticals, Jiangsu Hengrui Medicine, Jilin Sichang Pharmaceutical, Luoxin Pharmaceutical, Tibet Weixinkang Pharmaceutical, Huaren Pharmaceutical, and Tibet Duo Rui Pharmaceutical, among others.